Abstract:To achieve higher therapeutic efficiency with catabatic side effects, desirable nanocarriers should be designed to retain the loaded drug tightly during the systemic circulation, but release the drug rapidly and efficiently upon endocytosis by tumor cells. Herein, to achieve "off-on" controlled delivery of DOX, novel amphiphilic polyelectrolyte/prodrug nanoparticles (NPs) with cooperative pH-sensitivity were constructed via synergistic electrostatic and hydrophobic interactions between: Slightly positively charged methoxy polyethylene glycol-b-(poly(2-(diisopropylamino) ethyl methacrylate-co-aminopropyl methacrylamide) (PEDPA) copolymer and negatively charged cis-aconityl-doxorubicin (CAD) pro drug (termed as PEDPA/CAD NPs). With polymer-prodrug synergistic noncovalent interactions, the drug loading content of PEDPA/CAD NPs could be improved up to 12.6% With favorable serum stability, and significantly lowered the drug leakage to 2.5% within 24 h at pH 7.4. However, nearly 80% of encapsulated drug could be released at pH 5.0 within 12 h, due to the cooperative effects of the protonation of PDPA blocks resulting in quick disassembly of NPs and the rapid hydrolysis of cis-aconityl linkage leading to charge-reverse of CAD. Moreover, the results of fluorescent microscopy imaging and flow cytometry measurements exhibited that DOX could be recovered and released rapidly from PEDPA/CAD NPs upon endocytosis and then exert therapeutic action in the cell nucleus. Importantly, the PEDPA/CAD NPs exhibited significantly higher antitumor efficiency in vivo with reduced nonspecific toxicity to normal tissues in comparation with free DOX. In summary, the NPs designed in this work, constructed by synergistic electrostatic and hydrophobic interactions with cooperative pH-sensitivity, which potentially resolved the dilemma between systemic stability and rapid intracellular drug release, would provide a promising nanomedicine platform for cancer therapy:

Enhanced Therapeutic Efficacy with Hydrophobic Polyphosphoester-Based Nanoparticles Via Improved Intracellular Drug Release.

Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- Caprolactone) Bearing Pendant Hydroxyl Groups As Nanocarriers for Doxorubicin Delivery.

Self-assembled Amphiphilic Copolymers–doxorubicin Conjugated Nanoparticles for Gastric Cancer Therapy with Low in Vivo Toxicity and High Efficacy

Polymer-lipid Hybrid Nanoparticles Synchronize Pharmacokinetics of Co-Encapsulated Doxorubicin-Mitomycin C and Enable Their Spatiotemporal Co-Delivery and Local Bioavailability in Breast Tumor.

Polyphosphazene nanoparticles for cytoplasmic release of doxorubicin with improved cytotoxicity against Dox-resistant tumor cells.

Hyaluronic acid/PEGylated amphiphilic nanoparticles for pursuit of selective intracellular doxorubicin release

Nanoparticle carriers based on copolymers of poly(ε-caprolactone) and hyperbranched polymers for drug delivery.

High loading of hydrophilic/hydrophobic doxorubicin into polyphosphazene polymersome for breast cancer therapy.

Core-crosslinked Polyprodrug Nanoparticles Via Facile Crosslinking-Induced Self-Assembly for Tumor Intracellular Acid-Triggered Doxorubicin Delivery

Sequential thermo-induced self-gelation and acid-triggered self-release process of drug-conjugated nanoparticles: A strategy for the sustained and controlled drug delivery to tumors

Amphiphilic Polyelectrolyte/Prodrug Nanoparticles Constructed by Synergetic Electrostatic and Hydrophobic Interactions with Cooperative Ph-Sensitivity for Controlled Doxorubicin Delivery

Construction of Amphiphilic Copolymer Nanoparticles Based on Hyperbranched Poly (Amine-Ester) and 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine As Drug Carriers for Cancer Therapy.

Controlled release of doxorubicin from Poly-(D,L-lactide-co-glycolide) (PLGA) nanoparticles prepared by coaxial electrospraying

Core/Shell PEGS/HA Hybrid Nanoparticle Via Micelle-Coordinated Mineralization for Tumor-Specific Therapy.

Sustained Release of PTX-incorporated Nanoparticles Synergized by Burst Release of DOX⋅HCl from Thermosensitive Modified PEG/PCL Hydrogel to Improve Anti-Tumor Efficiency.

Biodegradable Interlayer-Crosslinked Polymer Micelles with Reduction Sensitivity for Non-Small Cell Lung Cancer Therapy.

Bioinspired Nanoplatform for Enhanced Delivery Efficiency of Doxorubicin into Nucleus with Fast Endocytosis, Lysosomal Ph-Triggered Drug Release, and Reduced Efflux.

Synthesis and physicochemical properties of doxorubicin-loaded PEGA containing amphiphilic block polymeric micelles

Targeted Delivery and Release of Doxorubicin Using A Ph-Responsive and Self-Assembling Copolymer

Dissipative Particle Dynamics Studies of Doxorubicin-Loaded Micelles Assembled from Four-Arm Star Triblock Polymers 4As-Pcl-b-pdeaema-b-ppegma and Their Ph-Release Mechanism.

Drug -driven self-assembly of pH-sensitive nano-vesicles with high loading capacity and anti-tumor efficacy?